Live feed
·
INSIDERFiling
Monopar Therapeutics Inc. logo

Chief Executive Officer Robinson Chandler converted options into 8,724 shares and covered exercise/tax liability with 2,558 shares, increasing direct ownership by 8% to 85,718 units (SEC Form 4)